Carilex Medical Inc
Carilex Medical Inc maintains a debt-to-equity ratio of 0.59, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a key flag noting that net cash is negative after subtracting total debt. This suggests that the company may need to manage its cash flow carefully to meet short-term obligations. In terms of profitability, Carilex Medical Inc's operating cash flow of TWD 46,566,000 indicates positive cash generation from operations. However, the company's capital expenditure of TWD -10,523,000 suggests that it is not currently investing heavily in new long-term assets. The company's return on invested capital (ROIC) and other profitability metrics are not provided, but the operating cash flow suggests a degree of operational efficiency. Carilex Medical Inc's revenue is concentrated in the European, American, New Zealand, Australian, and Taiwan markets. The company does not disclose specific segment revenues, so it is unclear whether any particular region or product line dominates its earnings. The geographic exposure suggests that the company is subject to regulatory and economic conditions in these regions, which could affect its performance. The company's growth trajectory is not explicitly outlined in the provided data, but the absence of significant capital expenditure may indicate a focus on maintaining current operations rather than expanding aggressively. The outlook for the current and next fiscal years is not provided, so it is difficult to assess the company's future performance based on the available data. The risk assessment for Carilex Medical Inc indicates a low potential for dilution, which is a positive sign for shareholders. However, the company's liquidity risk is assessed as medium, which could be a concern if cash flow from operations is not sufficient to cover short-term obligations. The company's debt structure, with long-term debt of TWD 172,144,000, suggests that it has a manageable debt burden, but the negative net cash position indicates that it may need to manage its liquidity carefully. Recent events and filings for Carilex Medical Inc are not detailed in the provided data, so it is not possible to assess the company's recent performance or strategic direction based on this information.
Business. Carilex Medical Inc designs, manufactures, and sells medical equipment, including therapeutic support surfaces and negative pressure wound therapy machines, primarily for markets in Europe, the United States, New Zealand, Australia, and Taiwan.
Classification. Carilex Medical Inc is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.
- Carilex Medical Inc has a moderate debt-to-equity ratio of 0.59, indicating a balanced capital structure.
- The company generates positive operating cash flow, which is a positive sign for liquidity and operational efficiency.
- The company's revenue is concentrated in several key international markets, which may expose it to regional economic and regulatory risks.
- The company's liquidity risk is assessed as medium, and it has a low potential for dilution, which is favorable for shareholders.
- The company is not currently investing heavily in new long-term assets, as indicated by its capital expenditure.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.